TAKEDA-Farmaceuticos Portugal, Lda secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2025/1589 - MARIBAVIR [200 MG COMP]

Posted On: 2026-05-15

Portugal, May 15 -- Portugal based TAKEDA-Farmaceuticos Portugal, Lda has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2025/1589 - MARIBAVIR [200 MG COMP]. The value of the contract is worth 55207570 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

TAKEDA-Farmaceuticos Portugal, Lda secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 2025/1589 - MARIBAVIR [200 MG COMP]